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ABSTRACT
The complete nucleotide sequence of the hemagglutinin (HA) gene of the
human type B influenza virus B/Singapore/222/79 is presented. Comparison
with the only other known sequence of a B hemagglutinin (B/Lee/40) shows
that antigenic drift in type B HA genes is essentially the same as already
observed within the influenza A H3 subtype, i.e., an accumulation of point
mutations. The main difference is that the apparent evolution is
significantly slower, most likely due to the cumulative effect of a lower
occurrence in the population (slower evolution) and/or less immunological
pressure. There is a striking cluster of changes at positions 127 until
137 of the HAl subunit which may represent one of the antigenic sites of
the molecule.
INTRODUCTION
Antigenic variation in influenza A viruses has been studied extensively
both for the hemagglutinin (1,2) and more recently for the neuraminidase
(3-10). For influenza B, however, much less information about its surface
antigens is available, with only the structure of one hemagglutinin gene
(11) and one neuraminidase gene (12), both from influenza B/Lee/40, having
been published so far. Antigenic shift has not been observed in type B
viruses which may be due to the absence of a gene pool of influenza B
viruses in animals (13). Antigenic drift, however, has been shown to
occur, but at a slower rate than in influenza A (14,15). Studies with
monoclonal antibodies, directed against the HA of B/Lee/40 virus also
indicated that the B type HA is less variable than the A type HA (16,17).
Comparison of the influenza B/Lee/40 HA with the type A hemagglutinins
shows a remarkable conservation of the major structural features of the HAs
of both type A and B viruses, suggesting a close evolutionary relationship
of the corresponding genes (11).
In this paper, we present the complete nucleotide sequence of the HA
gene of B/Singapore/222/79 virus. This virus strain is present in
influenza vaccines for use during the 1983-1984 season, as recommended by
the World Health Organization (18).
© I R L Press Limited, Oxford, England.
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MATERIALS AND METHODS
Viral and bacterial strains
The influenza strain B/Singapore/222/79 was a generous gift of the
companies Duphar (Weesp, Holland) and M6rieux (Marcy l'Etoile, France).
The viral RNA was extracted according to the procedure of Palese and
Schulman (19). Plasmid pBR322 derivatives, containing viral DNA inserts,
were propagated in E. coli DHl cells (20,21).
Construction of recombinant plasmids containing influenza genes
The equimolar mixture of 8 viral RNAs ('t30 tpg) was 3'-polyadenylated
and converted to single stranded DNA copies with reverse transcriptase
followed by RNAase treatment as described previously (22). Second strand
synthesis was initiated with the dodecanucleotide primer d(AGTAGAAACAAG)
(Collaborative Research, Inc., Waltham, Mass.). The cDNA and the primer
(5,.g) were dissolved in 25'1J 80mM K;HPO4 (pH 6.9), boiled for 30 sec and
left to cool slowly to room temperature. The reaction mixture was diluted
to 50 1l by the addition of dithiotreitol (4 mM final concentration), MgCla,
(6 mM), K2HPO4 (140 mM), dNTPs (300uM), 50,uCi [OC_-3P]-dATP and 15 U DNA
polymerase I (Boehringer, Mannheim), and kept at 15 C for 3 h. The dsDNA
was purified by extraction with phenol/chloroform/isoamylalcohol (25:24:1)
followed by gel filtration on a G50 fine Sephadex column and precipitated
with isopropanol. dsDNA copies of the HA and NP gene were isolated after
fractionation of the crude mixture on a 1.5% agarose gel and cloned into
the Pst I site of pBR322 using the poly(dG)-poly(dC) tailing method (23).
Identification of HA specific inserts
Tetracycline and ampicilline sensitive colonies were screened for HA
and NP gene inserts using colony hybridization with a [32P](HA + NP)-RNA
probe as described previously (22). Positive clones were grouped by
restriction analysis and conclusively identified by sequence analysis of
both ends. However, the longest HA insert found lacked some information.
A suitable 3 P-labeled DNA restriction fragment located near the missing
end was used as a probe to rescreen our collection of HA and NP colonies
essentially following the procedure of Hanahan and Meselson (24).
Nucleotide sequence analysis of the HA gene
Sequence analysis was performed according to the procedures of Maxam
and Gilbert (for dG, dA, dC and dC + dT) (25) and Peattie (dG + dA) (26).
We used 0.25 mm x 60 cm sequencing gels, essentially prepared as described
by Ansorge and De Maeyer (27) and Garoff & Ansorge (28).
RESULTS AND DISCUSSION
Cloning and characterization of HA gene inserts
Synthesis of the second strand of a cDNA according to common standard
procedures makes use of the self-priming capacity of the cDNA, followed by
S1 nuclease treatment. It is inevitably coupled with the loss of some
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information corresponding to the 5'-end of the RNA. For cloning influenza
viral RNAs, there is an additional problem for first strand synthesis
because of its lack of a 3' poly A-tail. It is possible to polyadenylate
the viral RNA in vitro before first strand DNA synthesis (22). For
influenza A strains, both problems are overcome by the use of two
(commercially available) universal oligonucleotides to prime reverse
transcription (avoiding polyadenylation) and to initiate second strand DNA
synthesis (29-31). Lacking a suitable primer to initiate reverse
transcription for influenza B, we synthesized a ssDNA copy of the HA gene
in the conventional way using polyadenylation and oligo-(dT) priming (22).
Second strand synthesis, however, was primed with the dodecamer
d(AGTAGAAACAAG). As the HA and NP genes of influenza B viruses are nearly
of the same size (32), we ended up with a mixture of clones containing
dsDNA copies of both genes, and the HA specific clones were identified by
sequence analysis of the terminal regions. Clone pSHA2 had the complete
3'-sequence information (starting with the primer) but was incomplete at
the 5' terminus. A nick-translated 32P-labeled Hind III - Mbo I restriction
fragment positioned close to the 5' coding end of the pSHA2 insert was used
as a probe for colony hybridization. Several clones containing the missing
93 nucleotides were detected and sequenced (pSHA38, pSHA63 and pSHA68).
Nucleotide sequence
The nucleotide sequence of the influenza B/Singapore HA gene is shown
in Fig. 1. The entire viral RNA contains 1878 nucleotides and has the
coding capacity for a precursor polypeptide of 583 amino acids. At the 5'
end of the coding strand, a non-translated region of 33 nucleotides occurs,
while the 3' end shows an untranslated sequence of 96 residues.
Protein sequence
No protein sequence data on the B/Singapore/222/79 HA is available but
the amino acid terminal sequences of the HAl and HA2 subunits (33) and,
very recently, the nucleotide sequence of the B/Lee/40 HA (11) have been
determined. Comparison of the B/Singapore with the B/Lee HA (Fig. 1) shows
a high degree of homology and suggests the same build-up of the molecule.
The HA precursor starts with a 15 residue signal sequence, followed by an
HAl chain consisting of a maximum of 345 amino acids, and an HA2 peptide
composed of 223 residues. The HAl subunit may undergo further processing
by a carboxy-peptidase B-like enzyme and/or a trypsin-like enzyme (34).
Comparison of influenza B HAs
A comparison of the nucleotide and amino acid sequences of the HA of
B/Singapore/222/79 and B/Lee/40 virus is shown in Fig. 1. The B/Lee gene
contains an extra AAC triplet in the HAl peptide (coding for amino acid
165) and one extra G residue in the 3' untranslated region. An extra codon
insertion (also AAC) was first observed by us in a comparison of
A/Victoria/3/75 with A/Aichi/2/68 HA (35). Similar insertions (deletions)
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of MC or ACA triplets were found in several influenza A HA (35-37) and NA
genes (38), while AAA insertions were observed in laboratory variant
strains of the A/PR8/34 HA gene (39). In all these cases, the extra codon
was located in a very U + G-rich region of the (complementary) vRNA and for
chronological reasons, it seems that insertion is a more likely explanation
rather than a deletion. Insertion of a few nucleotides can readily be
explained by slippage of the viral polymerase (38). Slippage of the
reverse transcriptase during cDNA synthesis is another possible
explanation. But, since this has to our knowledge never been found when
other RNAs were converted to DNA using this enzyme and since the same
insertion was found in independent clones (22), this possibility must be
considered very unlikely. As the extra AAC-triplet is present in B/Lee/40,
it seems at face value that a deletion is more likely. But, it should be
noted that the B/Singapore/79 is not necessarily a direct descendant and
therefore an insertion during the evolution from a common ancestor gene to
B/Lee/40 is at least as probable.
The sequence comparison of two type B HAs shows the changes that have
resulted after 39 years of evolution. The number of nucleotide
substitutions is 133 (for the total gene) or 7.1% at the nucleotide level.
These substitutions give rise to 36 amino acid changes or 6.2%.
In the 5'-untranslated region, the three clustered substitutions,
GTT-4AGA (nucleotides 10-12) are observed. This is very remarkable, as
these substitutions occur in the region of the first 12 nucleotides of the
3' end of the vRNA, which is conserved to a high degree in all genes of the
same type of influenza virus. The 3'-untranslated region of the
B/Singapore HA shows 8 substitutions (the extra G in B/Lee/40 included)
with one of them changing the nature of the termination codon (UGA-.UAA).
This is, therefore, a second difference with the variation in influenza A,
where HA genes, belonging to the same subtype, have identical termination
codons and 3' untranslated sequences (1,35). Another remarkable difference
with the variation observed in influenza A viruses is the exact
conservation of the signal sequence as not even one silent nucleotide
substitution was observed. Possibly, this may even reflect a biological
function at the RNA level in this region implying that this region must be
Figure 1: Comparison of the hemagglutinin of B/Singapore/222/79 and
B/Lee/40 virus.
The complete nucleotide and predicted amino acid sequence of the
B/Singapore HA is shown. The B/Lee numbering is used. Only changes in
nucleotide sequence (underneath) and amino acid sequence (above) are
indicated for the B/Lee HA. The post-translational cleavage sites,
where the pre-HA is cleaved into a signal peptide (15 amino acids), an
HAl peptide (maximum 346 amino acids) and an HA2 peptide (223 amino
acids) are indicated by arrows. Potential glycosylation sites are
boxed. The site at residue 165 of HAl is absent in B/Lee (see text).
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Table I
Evolution of B Type HAs Compared with the Evolution of A type HAs
% substitutions in B type
% substitutions in A type
% nucleotide substitutions B type: 2.0
0.35
A type : 5.7
% amino acid substitutions B type : 2.0
0.22
A type: 9.1
Table 1: Only the HAl part has been taken into account. The evolution of
the B type was calculated for the HAl regions of B/Lee/40 and
B/Singapore/79. For the A-type data, A/Aichi/68 (35) and A/Bangkok/79 (40)
were used. The observed percentages were recalculated for a period of 10
years.
preserved in influenza B viruses.
As in influenza A HAs, the HAl peptide is the most variable part of the
molecule. The HAl subunit shows 7.8% nucleotide substitutions, giving rise
to 8.7% amino acid changes. For the HA2 region, these values amount to
only 6.1% and 2.7%, respectively. As we have explained before (35), the
occurrence of mutations in the two parts of the gene is undoubtedly of
similar frequency, but many more mutants in the HA2 part are selected away
because this domain fulfills an enzyme-like activity and the
structure-function constraint is very tight. Mutants in the HAl part, on
the other hand, occasionally confer a selective advantage in overriding
immunological barriers. Except for the extra triplet and an extra
G-residue (in the 3'-untranslated region), all substitutions can be
explained by point mutations. Our data shows that in general, the
antigenic drift observed in influenza B HAs is comparable with the drift
observed in influenza A HAs belonging to the H3 subtype (2,35). The
apparent rate of evolution, however, is significantly slower, especially at
the protein level. Comparing the drift between A/Aichi/2/68 (35) and
A/Bangkok/79 (40) with that between B/Lee/40 and B/Singapore/79, we
calculate for the B virus HAl that nucleotide substitutions occurred three
times slower and amino acid mutations occurred four times slower than in
their A-type counterparts (see Table 1). These data confirm and extend
previous studies on influenza B virus strains with monoclonal antibodies
which had suggested a lower variability (16,17).
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Glycosylation
The pattern of potential N-glycosylation sites varies slightly between
the type B HAs (Fig. 1). The B/Singapore HA shows eleven potential
carbohydrate attachment sites (one more than B/Lee/40 at position 145 of
the HAl peptide). This is not unusual as type A HAs, belonging to the same
subtype, also show slightly variable glycosylation patterns (1,35). For
the influenza B HAs, it is not known which of these potential sites have,
indeed, carbohydrates attached. Influenza B HAs show 4 potential
glycosylation sites at the C-terminus of their HA2 peptides, in contrast to
influenza A HAs which have, at most, 2 potential carbohydrate attachment
sites on their HA2 molecules (1,35). However, it seems highly unlikely
that there is a 4th carbohydrate unit attached to residue 216 of the HA2
since it is presumably located in the tail region inside the virion.
A possible antigenic site in influenza B HAs
Studies with monoclonal antibodies suggest that the B type HA has at
least three partially overlapping antigenic determinants (17).
Fig. 1 shows a very unequal distribution of the amino acid
substitutions over the molecule. Two thirds of the amino acid changes are
located in a region covering only 25% of the total HAl chain. The most
striking group of substitutions occurs in the cluster from residue 127
until 137. Three out of six changes in the cluster are infrequently found
in related protein pairs: Thr-4Arg, Arg-+Gly and Lys-4fle (41). The amino
acids are more conserved on both sides of this cluster. This is strongly
reminiscent of the structure of the proposed antigenic sites of the Hong
Kong HA (42) and suggests this cluster to be one of the predominant
antigenic determinants of the type B HA.
The studies of Krystal et al. (11) revealed extensive structural
similarities between influenza A and B HAs e.g., a nearly complete
conservation of cysteine residues. Comparison of the B/Singapore and
A/Aichi HA (35) sequence confirms these data and suggests a very similar
3-dimensional structure for A and B type HAs. Alignment of the B/Singapore
and A/Aichi HA sequences (Fig. 2) shows that the region containing residues
127 until 137 of the B/Singapore HAl corresponds to the region 123 until
133 of the A/Aichi HAl. This peptide segment occurs on a surface loop of
the globular part of the molecule, close to and presumably part of the
antigenic site A of the H3 HA and may play a similar role in B viruses. It
is also evident from Fig. 2 that the hydrophilic stop-transfer sequence
near the carboxy-terminus and the short hydrophilic tail are in exactly the
same positions in A and B viruses.
Concluding remarks
Antigenic variation in influenza B HAs does not seem to differ in
essential aspects from the drift observed within an A subtype HA. However,
the apparent rate of evolution proceeds significantly slower. Most likely,
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Figure 2: Comparison of the predicted amino acid sequences of the
U/Singapore/222/79 and A/Aichi/2/68 virus mature HAs.
Alignment of the sequences was done on the basis of conserved amino
acids between influenza A HAs. Homologous residues are underlined.
Potential glycosylation sites are marked with an asterisk. The amino acids
belonging to the proposed antigenic determinant of the B/Singapore HA are
represented in italics. The Aichi numbering is used. The membrane
spanning sequence is emphasized by a wavy line.
this can be explained as a combined effect of replication frequency
(possibly the number of infection cycles) and immunological pressure.
Influenza B is not as widespread in the human population -as influenza A,
consequently totalling less infection cycles and thereby reducing the total
error frequency. Also, there are less antibody carriers which reduces the
selection pressure for new antigenic variants. Many of the amino acid
subsitutions(due to point mutations) appear as clusters in a limited region
of the HAl subunit. The cluster containing residues 127-137 of the HAl may
represent one of the antigenic determinants of the B type HA.
Nevertheless, more data is required in order to obtain a detailed picture
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of the antigenically important domains of influenza B HA.
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